Acadia Healthcare Inc.
ACHC | NASDAQ
$28.37
+$0.04 (+0.14%)
At close: Sep 21, 2026, 4:00 PM ET
$28.37
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:18 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 3.31B | 3.15B | 2.93B | 2.61B | 2.31B | 2.09B |
Cost of Revenue | 2.73B | 2.44B | 2.25B | 100.2M | 90.7M | 87.24M |
Gross Profit | 583.44M | 711.98M | 682.61M | 2.51B | 2.22B | 2B |
Operating Income | 387.97M | 522.28M | 506.6M | 467.7M | 414.47M | n/a |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.07B | 341.88M | -25.36M | 374.14M | 275.76M | 183.8M |
Net Income | -1.1B | 255.61M | -21.67M | 273.14M | 190.64M | -672.13M |
Selling & General & Admin | 195.48M | 189.71M | 176.01M | 1.6B | 1.42B | 1.31B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | 445.6M | 390.16M | 690.32M |
Operating Expenses | 195.48M | 189.71M | 176.01M | 2.04B | 1.81B | 2B |
Interest Expense | 138.86M | 116.37M | 82.13M | 69.76M | 76.99M | 158.11M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.92B | 2.63B | 2.42B | 2.14B | 1.9B | 2.09B |
Income Tax Expense | 25.98M | 77.4M | -9.7M | 94.11M | 67.56M | 40.61M |
Shares Outstanding (Basic) | 90.71M | 91.62M | 90.95M | 89.68M | 88.77M | 87.88M |
Shares Outstanding (Diluted) | 90.71M | 92.06M | 90.95M | 91.56M | 90.79M | 88.6M |
EPS (Basic) | -12.16 | 2.79 | -0.24 | 3.05 | 2.15 | -7.65 |
EPS (Diluted) | -12.16 | 2.78 | -0.24 | 2.98 | 2.10 | -7.65 |
EBITDA | -737.83M | 607.84M | 189.11M | 561.67M | 459.47M | 437.16M |
EBIT | -927.08M | 458.25M | 56.77M | 443.9M | 352.75M | 341.9M |
Depreciation & Amortization | 189.25M | 149.6M | 132.35M | 117.77M | 106.72M | 95.26M |
Add to Watchlist
Select watchlists to add or remove ACHC